Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which workout helps heart surgery patients recover faster?

NCT ID NCT07438717

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two types of exercise training—moderate-intensity interval training and continuous training—in 56 adults aged 40-60 who had mitral valve replacement surgery 4-8 weeks earlier. Over 12 weeks, researchers measured walking ability, lung function, heart efficiency, and quality of life. The goal was to see which approach better helps patients regain strength and daily function after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Feb 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both male and female age 40-60 years * Hemodynamically stable heart rate and blood pressure * Patients 4-8 weeks post-mitral valve replacement (MVR) surgery * Stable medical condition for MIIT * Able to walk independently for at least 5 minutes without assistance * Stable pulmonary function without severe pulmonary complications (e.g., severe chronic obstructive pulmonary disease). * No ongoing respiratory infections or severe heart failure. Exclusion Criteria: * Presence of unstable angina, severe heart failure (ejection fraction \< 30%), or other significant cardiac arrhythmias that contraindicate exercise. * Conditions that limit mobility or the ability to perform exercises safely (e.g., severe arthritis, recent fractures, or neuromuscular diseases). * Patients with severe respiratory conditions (e.g., severe asthma or COPD exacerbation) that would limit participation in exercise. * Other serious co-morbidities (e.g., uncontrolled diabetes, severe hypertension, renal failure) that may impact safe participation in exercise. * Participation in any other structured exercise program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mitral valve disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

mitral valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mitral valve replacement

Contacts and locations

Locations

  • PIC Hospital, Lahore.

    Lahore, Punjab Province, 42000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.